About CHU Saint Eloi; Service d'Hématologie Clinique
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at CHU Saint Eloi; Service d'Hématologie Clinique
During the past decade, CHU Saint Eloi; Service d'Hématologie Clinique conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Saint Eloi; Service d'Hématologie Clinique"
#1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at CHU Saint Eloi; Service d'Hématologie Clinique
According to Clinical.Site data, the most researched conditions in "CHU Saint Eloi; Service d'Hématologie Clinique" are
"Follicular Lymphoma" (1 trials), "Lymphoma" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials) and "Relapsed or Refractory Follicular Lymphoma" (1 trials). Many other conditions were trialed in "CHU Saint Eloi; Service d'Hématologie Clinique" in a lesser frequency.
Clinical Trials Intervention Types at CHU Saint Eloi; Service d'Hématologie Clinique
Most popular intervention types in "CHU Saint Eloi; Service d'Hématologie Clinique" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Obinutuzumab" (2 trials), "Rituximab" (2 trials), "Bendamustine" (1 trials), "Glofitamab" (1 trials) and "Lenalidomide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CHU Saint Eloi; Service d'Hématologie Clinique
The vast majority of trials in "CHU Saint Eloi; Service d'Hématologie Clinique" are
4 trials for "All" genders.
Clinical Trials Status at CHU Saint Eloi; Service d'Hématologie Clinique
Currently, there are NaN active trials in "CHU Saint Eloi; Service d'Hématologie Clinique".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in CHU Saint Eloi; Service d'Hématologie Clinique,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CHU Saint Eloi; Service d'Hématologie Clinique, 2 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".